Pharmala Biotech Holdings Inc. (CSE:MDMA)

Market Cap	9.55M
Revenue	n/a
Net Income	n/a
Shares Out	106.10M
EPS	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	96,267
Average Volume	294,548
Open	0.0950
Previous Close	0.0900
Day's Range	0.0900 - 0.0950
52-Week Range	0.0650 - 0.3400
Beta	0.96
RSI	39.01
Earnings Date	Jul 25, 2025

About Pharmala Biotech Holdings

Pharmala Biotech Holdings Inc., doing business as PharmAla, engages in the development, manufacture and sale of MDMA and MDXX class molecules in service to the burgeoning clinical research community. The company offers its MDMA drug active pharmaceutical ingredient under the LaNeo brand name. Pharmala Biotech Holdings Inc. is headquartered in Vancouver, Canada.

• Industry: Biotechnology
• Sector: Healthcare
• CEO: Nicholas Kadysh
• Country: Canada
• Stock Exchange: Canadian Securities Exchange
• Ticker Symbol: MDMA